Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
01/03/2014 | CA2875461A1 3-o-heteroaryl-ingenol |
01/02/2014 | US20140005391 Quinazoline based egfr inhibitors |
01/02/2014 | US20140005182 Aryl Methyl Benzoquinazolinone M1 Receptor Positive Allosteric Modulators |
01/02/2014 | US20140005180 Phenyl amino pyrimidine compounds and uses thereof |
01/02/2014 | US20140005178 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
01/01/2014 | EP2679586A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
01/01/2014 | EP2679583A1 Mesoionic pesticides |
01/01/2014 | EP2678317A1 Benzamide derivatives as p2x7 receptor antagonists |
01/01/2014 | CN103492370A Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
01/01/2014 | CN103483323A Avanafil |
01/01/2014 | CN103483277A Preparation method and application of anilinoquinazoline compound |
01/01/2014 | CN103483276A Preparation method for vandetanib impurity |
01/01/2014 | CN103483275A Coupling compound of NSAID anti-inflammatory pain killers and EGFR kinase inhibitor and synthetic method and application of coupling compound |
01/01/2014 | CN103483274A Method for preparing bensulfuron methyl |
01/01/2014 | CN103483273A 6-methyl-5-fluorine-2,4-pyrimidinediamine compound and preparation and application thereof |
01/01/2014 | CN103483272A Resorcarenes-polysubstitution pyrimidine derivative as well as preparation method and application of derivative |
01/01/2014 | CN103483271A Preparation method of hydrogen bond self-assembly supramolecular photopolymerizable monomers |
01/01/2014 | CN103483270A Synthetic method of 2-(4, 6-dimethyl pyrimidine-2-base amino formyl amino sulfonyl) methyl benzoate |
01/01/2014 | CN103483269A Preparation methods for rosuvastatin calcium and intermediates thereof |
01/01/2014 | CN103483268A Method for preparing 4, 6-dichloro-2-methyl-5-nitro pyrimidine |
01/01/2014 | CN103483251A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
01/01/2014 | CN102532038B Method for preparing 2-methyl-1-pyrimidine-5-yl-1-(4-fluoroform methoxyl phenyl) allene-1-alcohol |
12/31/2013 | US8618296 Arylethynyl derivatives |
12/31/2013 | US8618291 Process for preparing 4-[(1,6-dihydro-6-OXO-2-pyrimidinyl)amino]benzonitrile |
12/31/2013 | US8618290 HSP90 inhibitors |
12/31/2013 | US8618289 RAF kinase modulator compounds and methods of use thereof |
12/31/2013 | US8618288 Pyrimidine compounds as serotonin receptor modulators |
12/31/2013 | US8618169 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
12/31/2013 | US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
12/31/2013 | US8618121 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors |
12/31/2013 | US8618111 5-alkynyl-pyrimidines |
12/31/2013 | US8618103 Inhibitors of JAK |
12/31/2013 | US8618097 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
12/31/2013 | CA2755268C Erbb inhibitors |
12/31/2013 | CA2629814C Bisamide inhibitors of hedgehog signaling |
12/31/2013 | CA2622642C Dipeptidyl peptidase inhibitors |
12/31/2013 | CA2552565C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
12/31/2013 | CA2542492C Sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
12/27/2013 | WO2013192345A1 Complement pathway modulators and uses thereof |
12/27/2013 | WO2013191112A1 Fused heterocyclic compound |
12/27/2013 | WO2013191041A1 Amide compound and use thereof for pest control |
12/27/2013 | CA2877526A1 Complement pathway modulators and uses thereof |
12/27/2013 | CA2877089A1 Novel 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof |
12/26/2013 | US20130345219 Triazinone and diazinone derivatives useful as hsp90 inhibitors |
12/26/2013 | US20130345208 Ion channel modulators and methods of use |
12/26/2013 | US20130345180 2,4- diaminopyrimidine derivatives |
12/25/2013 | EP2675794A1 Selective fak inhibitors |
12/25/2013 | EP2675793A1 Fak inhibitors |
12/25/2013 | EP2675792A1 Substituted aminobutyric derivatives as neprilysin inhibitors |
12/25/2013 | EP2455371B1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
12/25/2013 | EP2149564B1 Substituted pyrimidine ether compounds and their use |
12/25/2013 | CN103477463A Organic light-emitting element, organometallic complex, light-emitting device, electronic appliance and lighting device |
12/25/2013 | CN103468245A OLED material with carrier transmittability as well as preparation method and application thereof |
12/25/2013 | CN103467458A Preparation methods for rosuvastatin calcium and intermediates thereof |
12/25/2013 | CN103467390A Method for preparing 2-amino-4(3H)-quinazolinones |
12/25/2013 | CN103467389A Copper-catalyzed synthesis method of quinazoline |
12/25/2013 | CN103467388A Method for synthesizing aryl or heteroaryl substituted quinazoline compound |
12/25/2013 | CN103467387A Method of preparing azoxystrobin and intermediate thereof |
12/25/2013 | CN103467386A Aryl pyrimidine ortho-position monocyano compounds and synthesis method thereof |
12/25/2013 | CN102146076B Anilinoquinazoline derivatives and preparation method thereof |
12/25/2013 | CN102026984B Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols |
12/25/2013 | CN101100466B Non-reversible protein tyrosine phosphorus acylase inhibitor and its preparation and application |
12/24/2013 | US8614320 Preparation of aminopyrimidine compounds |
12/24/2013 | US8614319 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
12/24/2013 | US8614229 Substituted indole derivatives and methods of use thereof |
12/24/2013 | US8614223 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
12/24/2013 | US8614222 Methods of preventing and treating low bone mass diseases |
12/24/2013 | US8614220 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
12/24/2013 | US8614201 Heterocyclic amides as modulators of TRPA1 |
12/24/2013 | DE112012000828T5 Lichtemittierendes Element The light-emitting element |
12/24/2013 | CA2567821C Quinazolinone derivatives useful as vanilloid antagonists |
12/24/2013 | CA2561059C Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
12/19/2013 | WO2013186706A1 Process for the preparation of bosentan |
12/19/2013 | WO2013185309A1 Rosuvastatin calcium and method for preparing intermediate thereof |
12/19/2013 | US20130338360 Method for the preparation of high-purity pharmaceutical intermediates |
12/19/2013 | US20130338167 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety |
12/19/2013 | US20130338151 Fused ring analogues of anti-fibrotic agents |
12/19/2013 | US20130338147 4,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases |
12/19/2013 | US20130337052 System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication |
12/19/2013 | US20130336918 Compounds and methods for inhibiting phosphate transport |
12/18/2013 | EP2674420A1 Method for producing aminophenyl pyrimidinyl alcohol derivative, and synthesis intermediate thereof |
12/18/2013 | EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation |
12/18/2013 | EP2421832B1 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops |
12/18/2013 | EP2398779B1 New process for the preparation of nitroorotic acid |
12/18/2013 | EP2360156B1 Method for manufacturing neuraminic acid derivatives |
12/18/2013 | EP1782800B1 Methods for detecting JAK3 inhibitors |
12/18/2013 | EP1439187B1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
12/18/2013 | CN103459573A Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones |
12/18/2013 | CN103459375A Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device |
12/18/2013 | CN103459369A 胍化合物 Guanidine compound |
12/18/2013 | CN103450882A Phosphor |
12/18/2013 | CN103450097A Preparation method of high-purity crystal-form-A erlotinib hydrochloride |
12/18/2013 | CN103450096A Two nitrogen mustard derivatives, as well as preparation method and application therefore in tumor treatment |
12/18/2013 | CN103450095A Mercuric sulfamonomethoxine and preparation method thereof |
12/18/2013 | CN103450094A Method for purifying 4, 6-dichloro pyrimidine |
12/18/2013 | CN103450077A IRE-1A inhibitors |
12/18/2013 | CN102234266B Preparation and application of tetrahydrofolic acid ring-opened analogs with aziridine structure |
12/17/2013 | US8609852 Thiazolyl mGluR5 antagonists and methods for their use |
12/17/2013 | US8609841 Method for the preparation of erlotinib |
12/17/2013 | US8609839 Camphor-derived compounds, method for manufacturing the same, and application thereof |